[HTML][HTML] Understanding interleukin 11 as a disease gene and therapeutic target
SA Cook - Biochemical journal, 2023 - portlandpress.com
Interleukin 11 (IL11) is an elusive member of the IL6 family of cytokines. While initially
thought to be a haematopoietic and cytoprotective factor, more recent data show instead that …
thought to be a haematopoietic and cytoprotective factor, more recent data show instead that …
Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target
S O'Reilly - Clinical and Experimental Immunology, 2023 - academic.oup.com
Interleukin-11 is a cytokine from the IL-6 family of cytokines that includes IL-6 and oncostatin-
M. Initially described for its role in platelet generation, it is now appreciated that this cytokine …
M. Initially described for its role in platelet generation, it is now appreciated that this cytokine …
Longitudinal Assessment of Nasopharyngeal Biomarkers Post-COVID-19: Unveiling Persistent Markers and Severity Correlations
FJ Redondo-Calvo, Y Rabanal-Ruiz… - Journal of Proteome …, 2024 - ACS Publications
SARS-CoV-19 infection provokes a variety of symptoms; most patients present
mild/moderate symptoms, whereas a small proportion of patients progress to severe illness …
mild/moderate symptoms, whereas a small proportion of patients progress to severe illness …
Metabolic and mitochondria alterations induced by SARS‐CoV‐2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10
BD López‐Ayllón, S Marin… - Journal of Medical …, 2024 - Wiley Online Library
Antiviral signaling, immune response and cell metabolism are dysregulated by SARS‐CoV‐
2, the causative agent of COVID‐19. Here, we show that SARS‐CoV‐2 accessory proteins …
2, the causative agent of COVID‐19. Here, we show that SARS‐CoV‐2 accessory proteins …
Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2-infected mice and reduces endotheliopathy
MÁ Rodríguez-Hernández, M Baena-Bustos… - Ebiomedicine, 2024 - thelancet.com
Background SARS-CoV-2 infection is considered as a relapsing inflammatory process with a
dysregulation of IL-6 signalling. Classic IL-6 signalling is thought to represent a defence …
dysregulation of IL-6 signalling. Classic IL-6 signalling is thought to represent a defence …
Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection
Introduction Serum levels of interleukin-6 (IL-6) are increased in COVID-19 patients. IL-6 is
an effective therapeutic target in inflammatory diseases and tocilizumab, a monoclonal …
an effective therapeutic target in inflammatory diseases and tocilizumab, a monoclonal …
Dynamic Cellular Proteome Remodeling during SARS-CoV-2 Infection. Identification of Plasma Protein Readouts
FM Dos Santos, J Vindel-Alfageme… - Journal of proteome …, 2024 - ACS Publications
The outbreak of COVID-19, led to an ongoing pandemic with devastating consequences for
the global economy and human health. With the global spread of SARS-CoV-2 …
the global economy and human health. With the global spread of SARS-CoV-2 …
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
X Di, Y Li, J Wei, T Li, B Liao - Advanced Science, 2025 - Wiley Online Library
As the final stage of disease‐related tissue injury and repair, fibrosis is characterized by
excessive accumulation of the extracellular matrix. Unrestricted accumulation of stromal …
excessive accumulation of the extracellular matrix. Unrestricted accumulation of stromal …
Induction of the Inflammasome by the SARS‐CoV‐2 Accessory Protein ORF9b, Abrogated by Small‐Molecule ORF9b Homodimerization Inhibitors
E Zodda, M Pons… - Journal of Medical …, 2025 - Wiley Online Library
Viral accessory proteins play critical roles in viral escape from host innate immune
responses and in viral inflammatory pathogenesis. Here we show that the SARS‐CoV‐2 …
responses and in viral inflammatory pathogenesis. Here we show that the SARS‐CoV‐2 …
Effects of Combined Treatment with Sodium Dichloroacetate and Sodium Valproate on the Genes in Inflammation-and Immune-Related Pathways in T Lymphocytes …
D Stakišaitis, L Kapočius, V Tatarūnas, D Gečys… - Pharmaceutics, 2024 - mdpi.com
The study presents data on the anti-inflammatory effects of a combination of sodium
dichloroacetate and sodium valproate (DCA–VPA) on the expression of inflammation-and …
dichloroacetate and sodium valproate (DCA–VPA) on the expression of inflammation-and …